Faeth Therapeutics, Inc. — Form 8-K
Filed July 23, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Faeth Therapeutics (market cap ~$7.1M) filed an 8-K on 2026-07-23 disclosing Item 5.02 regarding departure of directors/officers and compensatory arrangements. The filing document references exist but specific counterparties, dollar amounts, share counts, vesting schedules, and concrete details of any compensation or departure are not provided in this filing header text.
Why this rating
Standard 8-K disclosure of officer/director matters. Without specifics on amount, person, or terms, cannot assess materiality. Routine filing for public company.
Extracted items
See more from July 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.